Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3321

Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022

LI 16853
Pages: 235
Dec 2016 | 2351 Views
face gplus_n
Author's : Pallavi Jaiswal
Tables: 103
Charts: 102
twit_n pr_n

Asia Pacific in Vitro Fertilisation Market Overview:

Asia Pacific in Vitro Fertilisation Market, valued at $3.0 billion in 2015, is estimated to reach $7.1 billion by 2022, growing at a CAGR of 13.3% during the forecast period. The Asia-Pacific in vitro fertilisation market is the fastest growing market of the global in vitro fertilisation market.

The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability. In addition, unprecedented growth in the service sector in this region has led to stress and anomalous lifestyle, which is the leading cause of male and female infertility. Advanced developing nations, such as India and China, have rapid increase in nuclear families triggering the concern for proper parenting among young couples leading to delay in parenthood. Rising aging population in the region is the major concern for governments across the APAC countries.

The fertility rates in some of the Asia-Pacific countries, namely Japan, North and South Korea, China, Vietnam, Singapore, and Thailand, are below the threshold replacement fertility level, i.e. 2.1 birth per 1000 women. According to the East West Center Study, Asia’s prosperous economies namely, Japan, South Korea, Singapore, and Taiwan, have the lowest birth rate, worldwide. Taiwan had the lowest birth per women, which was 8.55 birth per 1000 women, as compared to that of other countries such as South Korea (8.26), Japan (8.07) and Singapore (8.1) in 2014.

Percentage of People who Perceived Various Infertility Factors (Singapore, Thailand, Indonesia, and China)

Percentage of People who Perceived Various Infertility Factors (Singapore, Thailand, Indonesia, and China)

The Asia-Pacific in vitro fertilization market report analyzes the market based on three segments: end users, cycle type, and country. Based on cycle type, it is categorized into fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. Based on end users, it is classified into fertility clinics, hospitals, surgical centers, and clinical research institute. Based on country, the Asia-Pacific in vitro fertilization market is analyzed across India, China, Japan, Australia, New Zealand, Korea, Thailand, Singapore, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.

Vietnam in Vitro Fertilization Market, Volume and Value, 2014-2022, (Thousand, $Million)

Vietnam in Vitro Fertilization Market, Volume and Value, 2014-2022, (Thousand, $Million)

In Vietnam, the infertility rate decreased from 1.93 children per 1000 women in 2010 to 1.85 in 2014, which is less as compared to the globally accepted rate of 2.33 children per woman. The decrease in fertility rate has led to a decline in birth rate from 17.29 per 1,000 people in 2010 to 16.26 per 1,000 people in 2014. The cost of fresh IVF treatment in Vietnam is approximately $2,100-$2,500 per cycle of treatment, which is the cheapest in the Southeast Asian region. In addition, the success rate of the treatment is around 50% to 60%, which is reasonable as compared to that of Indonesia, Thailand, which has a success rate of 30% to 40%.

Key Benefits for Stakeholders

  • This report provides an in-depth analysis of the Asia-Pacific IVF market across twelve major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
  • The report includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.
  • This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.
  • The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022.
  • Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.

Asia Pacific in Vitro Fertilisation Market Key Segments:

By End Users (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type, (Value and Volume)

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycles

By Cycle Type Country Level Analysis (Value and Volume)

  • India
  • China
  • Japan
  • Australia
  • New Zealand
  • Korea
  • Thailand
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
  • Vietnam
  • Rest of Asia-Pacific
 

Chapter: 1. INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Coverage and limitations
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY

Chapter: 3. ASIA-PACIFIC IVF MARKET ANALYSIS

3.1. Market definition and scope
3.2. Overview
3.3. Drivers

3.3.1. Delay in family planning reduces chances of conception
3.3.2. Decline in birth rate
3.3.3. Emotional problems

3.4. Restraints
3.5. Asia-Pacific IVF Market, by Country
3.6. Asia-Pacific IVF Market by Cycle Types
3.7. Asia-Pacific IVF Market by End Users
3.8. Company Profile

3.8.1. Thermo Fisher Scientific, Inc.
3.8.2. Merck KGaA

Chapter: 4. INDIA IVF MARKET

4.1. Overview
4.2. India IVF Market by End Users

4.2.1. Fertility clinics
4.2.2. Hospitals
4.2.3. Surgical centres
4.2.4. Clinical research institutes

4.3. India IVF Market by Cycle Type

4.3.1. Fresh IVF cycles (non-donor)
4.3.2. Thawed IVF cycles (non-donor)
4.3.3. Donor egg IVF cycles

4.4. Drivers
4.5. Restraints
4.6. Regulatory issues, legislations, and authorities
4.7. Insurance reimbursement scenario
4.8. Company/Hospitals/Clinics Profile

4.8.1. Sun Pharmaceutical Industries Ltd.
4.8.2. Trivector Origio Scientific Pvt. Ltd
4.8.4. Lab IVF Asia Pte. Ltd.
4.8.5. LG Life Sciences.
4.8.6. Cadila Healthcare Ltd. (Zydus Cadila group)
4.8.7. Bourn Hall Clinic
4.8.8. Morpheus IVF Fertility Center
4.8.9. Southend Fertility and IVF Centre
4.8.10. Nova IVI Fertility
4.8.11. Bloom Fertility Center
4.8.12. Manipal Ankur
4.8.13. Cloudnine

Chapter: 5. CHINA IVF MARKET

5.1. Overview
5.2. China IVF Market by End Users

5.2.1. Fertility clinics
5.2.2. Hospitals
5.2.3. Surgical centers
5.2.4. Clinical research institutes

5.3. China IVF Market by Cycle Type

5.3.1. Fresh IVF cycles (non-donor)
5.3.2. Thawed IVF cycles (non-donor)
5.3.3. Donor egg IVF cycles

5.4. Drivers

5.4.1. Increased rate of infertility
5.4.2. Change in lifestyle

5.5. Restraints

5.5.1. Cost of living

5.6. Regulatory issues, legislations, and authorities
5.7. Insurance reimbursement scenario
5.8. Company/Hospitals/Clinics Profile

5.8.1. Cook Medical, Inc.
5.8.2. Vitrolife AB
5.8.3. Centre for Reproductive Medicine
5.8.4. Reproductive & Genetic Hospital Citic-Xiangya
5.8.5. Shenyang International Hospital
5.8.6. Shandong Provincial Hospital

Chapter: 6. JAPAN IVF MARKET

6.1. Overview
6.2. Japan IVF Market by End Users

6.2.1. Fertility clinics
6.2.2. Hospitals
6.2.3. Surgical centers
6.2.4. Clinical research institutes

6.3. Japan IVF Market by Cycle Type

6.3.1. Fresh IVF cycles (non-donor)
6.3.2. Thawed IVF cycles (non-donor)

6.4. Drivers
6.5. Restraints
6.6. Regulatory issues, legislations, and authorities
6.7. Insurance reimbursement scenario
6.8. Company/Hospitals/Clinics Profile

6.8.1. Merck KGaA
6.8.2. IVF Namba Clinic
6.8.3. Iwaki Women’s Clinic
6.8.4. Sanno Hospital

Chapter: 7. AUSTRALIA IVF MARKET

7.1. Overview
7.2. Australia IVF Market by End Users

7.2.1. Fertility clinics
7.2.2. Hospitals
7.2.3. Surgical centers
7.2.4. Clinical research institutes

7.3. Australia IVF Market by Cycle Type

7.3.1. Fresh IVF cycles (non-donor)
7.3.2. Thawed IVF cycles (non-donor)

7.4. Drivers
7.5. Restraints

7.5.1. Emotional and physical stress
7.5.2. No guarantee
7.5.3. Surplus embryos

7.6. Regulatory issues, legislations, and authorities

7.6.1. Common Law
7.6.2. Legislative responses to IVF
7.6.3. Non-legislative regulation for the practice of IVF

7.7. Insurance reimbursement scenario
7.8. Company/Hospitals/Clinics Profile

7.8.1. Genea Biomedx
7.8.2. Thermo Fisher Scientific, Inc.
7.8.3. Virtus Health
7.8.4. Monash IVF
7.8.5. City Fertility
7.8.6. Flinders Fertility

Chapter: 8. NEW ZEALAND IVF MARKET

8.1. Overview
8.2. New Zealand IVF Market by End Users

8.2.1. Fertility clinics
8.2.2. Hospitals
8.2.3. Surgical centres
8.2.4. Clinical research institutes

8.3. New Zealand IVF Market by Cycle Type

8.3.1. Fresh IVF cycles (non-donor)
8.3.2. Thawed IVF cycles (non-donor)
8.3.3. Donor egg IVF cycles

8.4. Drivers
8.5. Restraints
8.6. Regulatory issues, legislations, and authorities
8.7. Insurance reimbursement scenario
8.8. Hospitals/Clinics Profile

8.8.1. Fertility Associates
8.8.2. Fertility Plus
8.8.3. Reporomed

Chapter: 9. KOREA IVF MARKET

9.1. Overview
9.2. Korea IVF Market by End Users

9.2.1. Fertility clinics
9.2.2. Hospitals
9.2.3. Surgical centers
9.2.4. Clinical research institutes

9.3. Korea IVF Market by Cycle Type

9.3.1. Fresh IVF cycles (non-donor)
9.3.2. Thawed IVF cycles (non-donor)
9.3.3. Donor egg IVF cycles

9.4. Drivers
9.5. Restraints
9.6. Regulatory issues, legislations, and authorities
9.7. Insurance reimbursement scenario
9.8. Hospitals/Clinics Profile

9.8.1. Cha General Hospital
9.8.2. Maria Fertility Hospital

Chapter: 10. THAILAND IVF MARKET

10.1. Overview
10.2. Thailand IVF Market by End Users

10.2.1. Fertility clinics
10.2.2. Hospitals
10.2.3. Surgical centers
10.2.4. Clinical research institutes

10.3. Thailand IVF Market by Cycle Type

10.3.1. Fresh IVF cycles (non-donor)
10.3.2. Thawed IVF cycles (non-donor)
10.3.3. Donor egg IVF cycles

10.4. Drivers

10.4.1. Government initiatives
10.4.2. Surrogacy is economical as compared to developed countries
10.4.3. Boost in medical tourism

10.5. Restraints

10.5.1. Comparatively low success rate
10.5.2. Ethical issues in allowing gender selection

10.6. Regulatory issues, legislations, and authorities
10.7. Insurance reimbursement scenario
10.8. Hospitals/Clinics Profile

10.8.1. Bangkok Fertility Center
10.8.2. Siriraj Hospital
10.8.3. Ramathibodi Hospital
10.8.4. Perfect Woman Institute Piyavate Hospital
10.8.5. Jetanin Institute for Assisted Reproduction

Chapter: 11. SINGAPORE IVF MARKET

11.1. Overview
11.2. Singapore IVF Market by End Users

11.2.1. Fertility clinics
11.2.2. Hospitals
11.2.3. Surgical centers
11.2.4. Clinical research institutes

11.3. Singapore IVF Market by Cycle Type

11.3.1. Fresh IVF cycles (non-donor)
11.3.2. Thawed IVF cycles (non-donor)

11.4. Drivers

11.4.1. Government funding and tax rebates for parents
11.4.2. Rising infertility rate
11.4.3. Increase in success rate

11.5. Restraints

11.5.1. High cost of IVF treatment and lower success rate

11.6. Regulatory issues, legislations, and authorities
11.7. Insurance reimbursement scenario
11.8. Company/Clinics Profile

11.8.1. Irvine Scientific
11.8.2. ESCO Technologies Inc.
11.8.3. Leica Microsystems GMBH
11.8.4. NUH IVF Centre
11.8.5. Mount Elizabeth Fertility Center
11.8.6. Thomson Fertility Centre
11.8.7. Raffles Fertility Centre

Chapter: 12. MALAYSIAN IVF MARKET

12.1. Overview
12.2. Malaysia IVF Market by End Users

12.2.1. Fertility clinics
12.2.2. Hospitals
12.2.3. Surgical centers
12.2.4. Clinical research institutes

12.3. Malaysia IVF Market by Cycle Type

12.3.1. Fresh IVF cycles (non-donor)
12.3.2. Thawed IVF cycles (non-donor)
12.3.3. Donor egg IVF cycles

12.4. Drivers

12.4.1. Increase in government initiatives
12.4.2. Increase in the number of foreign patients
12.4.3. Decrease in rate of fertility and growing acceptability of IVF

12.5. Restraints
12.6. Regulatory issues, legislations, and authorities
12.7. Insurance reimbursement scenario
12.8. Clinics Profile

12.8.1. Subang Fertility Center
12.8.2. Concept Fertility Centre
12.8.3. TMC Fertility Center

Chapter: 13. INDONESIAN IVF MARKET

13.1. Overview
13.2. Indonesia IVF Market by End Users

13.2.1. Fertility clinics
13.2.2. Hospitals
13.2.3. Surgical centers
13.2.4. Clinical research institutes

13.3. Indonesia IVF Market by Cycle Type

13.3.1. Fresh IVF cycles (non-donor)
13.3.2. Thawed IVF cycles (non-donor)
13.3.3. Donor egg IVF cycles

13.4. Drivers

13.4.1. Increase in disposable income
13.4.2. Advances in IVF cycle technology
13.4.3. Decline in fertility rate

13.5. Restraints

13.5.1. Physical and emotional impact due to low success rate

13.6. Regulatory issues, legislations, and authorities
13.7. Insurance reimbursement scenario
13.8. Clinics Profile

13.8.1. Morula IVF
13.8.2. Yasmin IVF
13.8.3. Aster Fertility Clinic
13.8.4. Fertility Centre, Siloam Hospitals Surabana

Chapter: 14. PHILIPPINES IVF MARKET

14.1. Overview
14.2. Philippines IVF Market by End Users

14.2.1. Fertility clinics
14.2.2. Hospitals
14.2.3. Surgical centers
14.2.4. Clinical research institutes

14.3. Philippines IVF Market by Cycle Type

14.3.1. Fresh IVF cycles (non-donor)
14.3.2. Thawed IVF cycles (non-donor)
14.3.3. Donor egg IVF cycles

14.4. Drivers

14.4.1. Improve the replacement population
14.4.2. Advancement in technology

14.5. Restraints
14.6. Regulatory issues, legislations, and authorities
14.7. Insurance reimbursement scenario
14.8. Clinic Profile

14.8.1. Victory Art Lab
14.8.2. CRM-MIA-Philippines

Chapter: 15. VIETNAM IVF MARKET

15.1. Overview
15.2. Vietnam IVF Market by End Users

15.2.1. Fertility clinics
15.2.2. Hospitals
15.2.3. Surgical centers
15.2.4. Clinical research institutes

15.3. Vietnam IVF Market by Cycle Type

15.3.1. Fresh IVF cycles (non-donor)
15.3.2. Thawed IVF cycles (non-donor)
15.3.3. Donor egg IVF cycles

15.4. Drivers

15.4.1. Decline in fertility rate
15.4.2. Reasonable cost and good success rate

15.5. Restraints
15.6. Regulatory issues, legislations, and authorities
15.7. Insurance reimbursement scenario
15.8. Hospital/Clinic Profile

15.8.1. IVF Lab Tu Du Hospital Vietnam
15.8.2. IVF Van Hanh
15.8.3. Sinh Hospital
15.8.4. Tu Du - Ho Chi Minh City Vietnam

Chapter: 16. REST OF ASIA-PACIFIC IVF MARKET

16.1. Overview
16.2. Rest of Asia-Pacific IVF Market by End Users

16.2.1. Fertility clinics
16.2.2. Hospitals
16.2.3. Surgical centers
16.2.4. Clinical research institutes

16.3. Rest of Asia-Pacific IVF Market by Cycle Type

16.3.1. Fresh IVF cycles (non-donor)
16.3.2. Thawed IVF cycles (non-donor)
16.3.3. Donor egg IVF cycles

16.4. Drivers

16.4.1. Increase in disposable income
16.4.2. Advances in IVF technology
16.4.3. Decline in fertility rate

16.5. Restraints

16.5.1. Physical and emotional impact due to low success rate

16.6. Regulatory Issues, legislations, and Authorities
16.7. Insurance Reimbursement Scenario
16.8. Hospitals/Clinics Profile

16.8.1. Fertility Centre, Siloam Hospitals Surabana
16.8.2. CRM-MIA-Philippines
16.8.3. IVFAS

List of Tables

TABLE 1. ASIA-PACIFIC IVF CYCLES MARKET VOLUME, BY COUNTRY, 2014-2022(THOUSAND)
TABLE 2. ASIA-PACIFIC IVF MARKET REVENUE, BY COUNTRY, 2014-2022($MILLION)
TABLE 3. ASIA-PACIFIC IVF MARKET VOLUME, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 4. ASIA-PACIFIC IVF MARKET REVENUE, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 5. ASIA-PACIFIC IVF MARKET VOLUME, BY END USER, 2014-2022 (THOUSAND)
TABLE 6. ASIA-PACIFIC IVF MARKET REVENUE, BY END USER, 2014-2022 ($MILLION)
TABLE 7. THERMO FISHER SCIENTIFIC, INC., BUSINESS OVERVIEW
TABLE 8. COMPANY SNAPSHOT
TABLE 9. MERCK KGAA: BUSINESS OVERVIEW
TABLE 10. COMPANY SNAPSHOT
TABLE 11. INDIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 12. INDIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 13. INDIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 14. INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 15. INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 16. SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 17. COMPANY SNAPSHOT
TABLE 18. TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEW
TABLE 19. COMPANY SNAPSHOT
TABLE 20. COMPANY SNAPSHOT
TABLE 21. LG LIFE SCIENCE BUSINESS OVERVIEW
TABLE 22. COMPANY SNAPSHOT
TABLE 23. CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 24. COMPANY SNAPSHOT
TABLE 25. CHINA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 26. CHINA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 27. CHINA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 28. CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 29. CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 30. COOK MEDICAL, INC. BUSINESS OVERVIEW
TABLE 31. COMPANY SNAPSHOT
TABLE 32. VITROLIFE AB, INC. BUSINESS OVERVIEW
TABLE 33. COMPANY SNAPSHOT
TABLE 34. JAPAN IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 35. JAPAN IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 36. JAPAN IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 37. JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 38. JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 39. EMD SERONO INC BUSINESS OVERVIEW
TABLE 40. COMPANY SNAPSHOT
TABLE 41. AUSTRALIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 42. OUTCOMES OF CYCLES OF IVF BY WOMEN’S AGE GROUP, 2011
TABLE 43. AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 44. AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 45. AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 46. AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 47. GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 48. COMPANY SNAPSHOT
TABLE 49. THERMO FISHER SCIENTIFIC INC BUSINESS OVERVIEW
TABLE 50. COMPANY SNAPSHOT
TABLE 51. NEW ZEALAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 52. NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 53. NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 54. NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 55. NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 56. KOREA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 57. KOREA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 58. KOREA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 59. KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 60. KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 61. THAILAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 62. THAILAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 63. THAILAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 64. THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 65. THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 66. SINGAPORE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 67. SINGAPORE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 68. SINGAPORE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 69. SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 70. SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 71. IRVINE SCIENTIFIC BUSINESS OVERVIEW
TABLE 72. COMPANY SNAPSHOT
TABLE 73. ESCO TECHNOLOGIES BUSINESS OVERVIEW
TABLE 74. COMPANY SNAPSHOT
TABLE 75. LEICA MICROSYSTEMS GMBH BUSINESS OVERVIEW
TABLE 76. COMPANY SNAPSHOT
TABLE 77. MALAYSIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 78. MALAYSIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 79. MALAYSIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 80. MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 81. MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 82. INDONESIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 83. INDONESIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 84. INDONESIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 85. INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 86. INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 87. PHILIPPINES IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 88. PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 89. PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 90. PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 91. PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 92. VIETNAM IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 93. VIETNAM IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 94. VIETNAM IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 95. VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 96. VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 97. REST OF ASIA-PACIFIC IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 98. REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 100. REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 101. REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 102. IVF CYCLE COST PER CYCLE BY COUNTRY (2014)

List of Figures

FIGURE 1. PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY FACTORS (SINGAPORE, THAILAND, INDONESIA, AND CHINA)
FIGURE 2. INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIGURE 3. INDIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 4. INDIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 5. INDIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 6. INDIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 7. INDIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 8. INDIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 9. INDIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 10. CHINA FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIGURE 11. CHINA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 12. CHINA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 13. CHINA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 14. CHINA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 15. CHINA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 16. CHINA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 17. CHINA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 18. JAPAN: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIGURE 19. JAPAN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 20. JAPAN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 21. JAPAN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 22. JAPAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 23. JAPAN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 24. JAPAN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 25. AUSTRALIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIGURE 26. IVF SUCCESS RATE FOR AUSTRALIA
FIGURE 27. AUSTRALIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 28. AUSTRALIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 29. AUSTRALIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 30. AUSTRALIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 31. AUSTRALIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 32. AUSTRALIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 33. NEW ZEALAND TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIGURE 34. NEW ZEALAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 35. NEW ZEALAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 36. NEW ZEALAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 37. NEW ZEALAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 38. NEW ZEALAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 39. NEW ZEALAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 40. NEW ZEALAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 41. SOUTH KOREA TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIGURE 42. KOREA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 43. KOREA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 44. KOREA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 45. KOREA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 46. KOREA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 47. KOREA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 48. KOREA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 49. THAILAND FERTILITY RATE CHILD BORN/WOMEN (2014-2020)
FIGURE 50. THAILAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 51. THAILAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 52. THAILAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 53. THAILAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 54. THAILAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 55. THAILAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 56. THAILAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 57. SINGAPORE: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIGURE 58. SINGAPORE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 59. SINGAPORE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 60. SINGAPORE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 61. SINGAPORE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 62. SINGAPORE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 63. SINGAPORE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 64. MALAYSIA: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIGURE 65. MALAYSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 66. MALAYSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 67. MALAYSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 68. MALAYSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 69. MALAYSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 70. MALAYSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 71. MALAYSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 72. INDONESIAN FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIGURE 73. INDONESIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 74. INDONESIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 75. INDONESIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 76. INDONESIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 77. INDONESIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 78. INDONESIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 79. INDONESIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 80. PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIGURE 81. PHILIPPINES IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 82. PHILIPPINES IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 83. PHILIPPINES IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 84. PHILIPPINES IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 85. PHILIPPINES IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 86. PHILIPPINES IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 87. PHILIPPINES IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 88. VIETNAM FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIGURE 89. VIETNAM IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 90. VIETNAM IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 91. VIETNAM IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 92. VIETNAM IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 93. VIETNAM IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 94. VIETNAM IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 95. VIETNAM IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 96. REST OF ASIA-PACIFIC IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 97. REST OF ASIA-PACIFIC IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 98. REST OF ASIA-PACIFIC IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 99. REST OF ASIA-PACIFIC IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 100. REST OF ASIA-PACIFIC IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 101. REST OF ASIA-PACIFIC IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 102. REST OF ASIA-PACIFIC IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)

 

The Asia-Pacific region has witnessed changes in the living standards of people and modernization in society which has led to reduction in birth rates. The Asian IVF cycle market have faced several challenges such as growing geriatric population and limited availability of skilled workforce. These trends will affect the socio-economic development and progress of the markets in this region. The fertility rates in some of the Asia-Pacific countries, namely Japan, North and South Korea, China, Vietnam, Singapore, and Thailand, are below the threshold replacement fertility level, i.e. 2.1 birth per 1000 women. According to the East West Center Study, Asia’s prosperous economies namely, Japan, South Korea, Singapore, and Taiwan, have the lowest birth rate, worldwide. Taiwan had the lowest birth per women, which was 8.55 birth per 1000 women, as compared to that of other countries such as South Korea (8.26), Japan (8.07) and Singapore (8.1) in 2014. This was due to couples postponing parenthood and couples preferring few children or rather no children.

Thus, the countries in the Asia-Pacific region with lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF, ICSI, and donor egg, among others. In addition, the Asia-Pacific artificial reproductive treatment (ART) industry will witness significant growth, owing to the low cost of treatment in the region as compared to that of the western countries. Moreover, the success ratio of ART, especially IVF, has increased owing to technological advancements in this region. These factors have not only improved the birth rate in this region but have also fostered the growth of the medical tourism industry in this region. Malaysia, Thailand, Singapore, and India are the preferred medical tourism destinations in this region.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts